Old drugs, new target: repurposing metformin and doxycycline to fight cancer
NCT ID NCT03076281
Summary
This study tested whether two existing, commonly used drugs—metformin (for diabetes) and doxycycline (an antibiotic)—could help treat head and neck cancer. It involved a small group of patients who were scheduled to have their tumors surgically removed. The goal was to see if taking these drugs for a short time before surgery could change the cancer's biology and make it less aggressive.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL CAVITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.